학술논문

Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies.
Document Type
Article
Source
Science Signaling; 3/28/2023, Vol. 16 Issue 778, p1-18, 18p
Subject
ACUTE myeloid leukemia
PROTEIN-tyrosine kinases
REACTIVE oxygen species
SURVIVAL analysis (Biometry)
PROGRESSION-free survival
Language
ISSN
19450877
Abstract
Copyright of Science Signaling is the property of American Association for the Advancement of Science and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)